Yongmi An

Title: Yongmi An: Innovator in Antithrombotic Research

Introduction

Yongmi An is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of innovative therapies targeting blood coagulation.

Latest Patents

Yongmi An holds a patent for "Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof." This invention provides novel antigen binding peptides, such as an antibody or antibody fragment, that specifically bind to selective FXIa inhibitors and/or dual inhibitors of FXIa and plasma kallikrein. The invention further relates to methods of reducing the antithrombotic effect of FXIa inhibitors by administering a pharmaceutically effective dose of the antigen binding peptides. Additionally, it offers detection reagents and methods for detecting the level of FXIa inhibitors in biological samples. He has 1 patent to his name.

Career Highlights

Yongmi An is associated with Bristol-Myers Squibb Company, where he applies his expertise in the development of therapeutic solutions. His work has been instrumental in advancing the understanding of antithrombotic therapies.

Collaborations

Yongmi An has collaborated with esteemed colleagues such as Joseph M. Luettgen and Lumelle A. Schneeweis. Their combined efforts contribute to the innovative research environment at Bristol-Myers Squibb.

Conclusion

Yongmi An's contributions to the field of biochemistry, particularly in antithrombotic research, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies.